The essential oils of two species of Sideritis growing spontaneously in Bulgaria and Macedonia are reported, Sideritis scardica and Sideritis raeseri. The oils of S. scardica from different locations differed significantly: in the Macedonian sample alpha-cadinol (20%) predominated, while in the oil of Bulgarian samples the main components were diterpenic compounds and octadecenol (over 20%). This is the first report of ditrpenoids in essential oil of S. scardica. The oil of S. raeseri demonstrated a distinct chemical profile with its high concentration of sesquiterpenes, main components being germacrone (25%) and elemol acetate (15.9%). The observed qualitative variability of the oil composition of S. scardica of different geographic origin could be a result of different ecologic conditions but might also reflect the well-known tendency of some Sideritis species to hybridize.
The authors of the Short Communication “[PbAsSiiPr3]6 — the First Structurally Characterized Compound with Chemical Bonds between Lead and Arsenic” (C. von Hänisch, D. Nikolova, Z. Anorg. Allg. Chem. 2004, 630, 345—346) overlooked the quaternary phase K8NbPbAs5, published by Gascoin und Sevov [1]. Its crystal structure reveals the presence of [NbPbAs5]8— anions. Therefore this is the first structurally characterized compound with bonds between lead and arsenic. Nevertheless, [PbAsSiiPr3]6 remains the sole example of a molecular compound, characterized by single‐crystal X‐ray crystallography, containing such Pb—As bonds and organic substituents. The authors apologize for their oversight.See original Z. anorg. allg. Chem. 2004, 630, 3, 345
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.